Research articlePublished 27 Jan 2021
Clinical Characteristics of Recurrent-Positive Coronavirus Disease 2019 after Curative Discharge: A Retrospective Analysis of 15 Cases in Wuhan China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: In China, the patients with previously negative RT-PCR results again test positive during the post-discharge isolation period. We aimed to determine the clinical characteristics of these “recurrent-positive” patients. Methods: We retrospectively reviewed the data of 15 recurrent-positive patients and 107 control patients with non-recurrent, moderate COVID-19 treated in Wuhan, China. Clinical data and laboratory results were comparatively analyzed. Results: Recurrent-positive patients had moderate disease. The rate of recurrent-positive disease in our hospital was 1.87%. Recurrent-positive patients were significantly younger (43(35-54) years) than control patients (60(43-69) years) (P=0.011). The overall disease course was significantly longer in recurrent-positive patients (36(34-45) days) than in control patients (15(7-30) days) (P=0.001). The time required for the first conversion of RT-PCR results from positive to negative was significantly longer in recurrent-positive patients (14(10-17) days) than in control patients (6(3-9) days) (P=0.011). Serum COVID-19 antibody levels were significantly lower in recurrent-positive patients than in control patients (IgM: 13.69 ± 4.38 vs. 68.10 ± 20.85 AU/ mL, P=0.015; IgG: 78.53 ± 9.30 vs. 147.85 ± 13.33 AU/mL, P<0.0001). Conclusion: Recurrent-positive patients were younger than control patients. The first hospitalization time was significantly longer in recurrent-positive patients than in control patients. COVID-19 IgM/IgG antibody levels were significantly lower in recurrent-positive patients than in control patients, which may explain why the virus was not fully eliminated from the body and was able to replicate again after the initial “clinical cure.”
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Lan Chen”
- BylineArticles whose byline prints “Zhen-Yu Zhang”
- BylineArticles whose byline prints “Xiao-Bin Zhang”
- BylineArticles whose byline prints “Su-Zhen Zhang”
- BylineArticles whose byline prints “Qiu-Ying Han”
- BylineArticles whose byline prints “Zhi-Peng Feng”
- BylineArticles whose byline prints “Jian-Guo Fu”
- BylineArticles whose byline prints “Xiong-Xiao”
